🟢 Alzamend Neuro is trading 5.8% up in after-hours trading with immediate catalyst unclear

Alzamend Neuro is trading at $1.83 (+5.78%) in after-hours trading, with no confirmed catalyst identified for the rise.

• The company announced August 18 an upcoming September 29 presentation of Phase 1/2A lithium-imaging data; no new company announcement explaining the move appeared in the results.
• Broader markets were lower September 28 amid rising oil prices, Treasury yields and geopolitical concerns, which does not explain the stock’s opposite-direction move.
• No volume or verified after-hours activity details were available.